Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

ProQR Therapeutics N.V. - Ordinary Shares (NQ:PRQR)

1.530 +0.080 (+5.52%)
Streaming Delayed Price Updated: 11:49 AM EST, Feb 18, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about ProQR Therapeutics N.V. - Ordinary Shares

< Previous 1 2 3 4 5 Next >
News headline image
ProQR to Present its Axiomer® RNA Editing Technology at TIDES USA 2023
From ProQR Therapeutics N.V.
Via GlobeNewswire
News headline image
ProQR Announces Upcoming Investor Conferences in April and May
From ProQR Therapeutics N.V.
Via GlobeNewswire
News headline image
ProQR Announces Annual Meeting of Shareholders to be Held May 17, 2023
From ProQR Therapeutics N.V.
Via GlobeNewswire
News headline image
Why Safe & Green Holdings Shares Are Trading Higher By 30%; Here Are 20 Stocks Moving Premarket ↗
Gainers Boxed, Inc. (NYSE: BOXD) gained 43.3% to $0.2303 in pre-market trading after declining 6% on Wednesday. Boxed recently said it is evaluating potentially filing for relief under the U.S.... 
Via Benzinga
News headline image
Earnings Outlook For ProQR Therapeutics ↗
 
Via Benzinga
News headline image
Why Bed Bath & Beyond Shares Are Trading Lower By 15%? Here Are Other Stocks Moving In Thursday's Mid-Day Session ↗
Gainers SCYNEXIS, Inc. (NASDAQ: SCYX) shares climbed 68% to $2.8184 after the company announced an exclusive license agreement with GSK for Brexafemme, in which the company will receive an upfront... 
Via Benzinga
News headline image
S&P 500 Up 1%; Bluebird Bio Shares Plummet ↗
U.S. stocks traded higher toward the end of trading, with the S&P 500 gaining over 1% on Wednesday. The Dow traded up 0.74% to 32,632.35 while the NASDAQ rose 1.51% to 11,893.07. The S&P 500, also... 
Via Benzinga
News headline image
Why Shares of ProQR Therapeutics Dropped on Wednesday ↗
The clinical-stage biotech released fourth-quarter and full-year earnings. 
Via The Motley Fool
News headline image
Why Kodiak Sciences Shares Are Trading Higher By 18%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session ↗
Gainers LogicMark, Inc. (NASDAQ: LGMK) shares jumped 76.1% to $0.2466 after the company announced financial results for the year ended 2022. The company reported FY22 revenue of $11.9 million. 
Via Benzinga
News headline image
Nasdaq Rises 1%; US Pending Home Sales Increase In February ↗
U.S. stocks traded higher midway through trading, with the Nasdaq Composite gaining over 100 points on Wednesday. The Dow traded up 0.58% to 32,580.89 while the NASDAQ rose 1.09% to 11,843.85. The S&P... 
Via Benzinga
News headline image
US Stocks Open Higher, Dow Jumps Over 200 Points ↗
U.S. stocks traded higher this morning, with the Dow Jones gaining over 200 points on Wednesday. Following the market opening Wednesday, the Dow traded up 0.72% to 32,628.42 while the NASDAQ rose 1.33%... 
Via Benzinga
News headline image
ProQR Announces Initial Pipeline Targets and Highlights Axiomer® RNA Editing Platform Technology at R&D Event
From ProQR Therapeutics N.V.
Via GlobeNewswire
News headline image
ProQR Announces Successful Defense of a Key Axiomer® Patent Protecting ADAR-mediated RNA Editing
From ProQR Therapeutics N.V.
Via GlobeNewswire
News headline image
ProQR to Present at Upcoming Scientific and Industry Conferences
From ProQR Therapeutics N.V.
Via GlobeNewswire
News headline image
ProQR Therapeutics to Host Virtual R&D Event on March 29, 2023
From ProQR Therapeutics N.V.
Via GlobeNewswire
News headline image
Tesla To $175? Here Are 10 Other Price Target Changes For Friday ↗
Oppenheimer cut CarMax, Inc. (NYSE: KMX) price target from $100 to $75. . Oppenheimer analyst Brian Nagel maintained an Outperform rating on the stock. CarMax shares fell 1.3% to $56.47 in pre-market... 
Via Benzinga
News headline image
Dow Dips 600 Points; AMC Entertainment Shares Plunge ↗
U.S. stocks traded lower toward the end of trading, with the Dow Jones dropping over 600 points on Thursday. 
Via Benzinga
News headline image
SKLZ Stock Alert: Will Skillz Shares Get Delisted? ↗
Skillz (SKLZ) stock is worth checking on today as the company received a delisting notice from the New York Stock Exchange. 
Via InvestorPlace
News headline image
Why AMC Entertainment Shares Are Trading Lower By Around 13%? Here Are 59 Stocks Moving In Thursday's Mid-Day Session ↗
Gainers Core Scientific, Inc. (NASDAQ: CORZ) shares jumped 188% to $0.1471. Core Scientific shares dipped 75% on Wednesday after the company filed for Chapter 11 bankruptcy. 
Via Benzinga
News headline image
Why Are Chinese EV Stocks NIO, XPEV, LI on Watch Today? ↗
Chinese electric vehicle (EV) stocks are a chief concern among investors today as these shares see mixed trading on Thursday! 
Via InvestorPlace
News headline image
Why Is ProQR (PRQR) Stock Up 83% Today? ↗
ProQR (PRQR) stock is rising on Thursday thanks to an expanded licensing and collaboration agreement with Eli Lilly (LLY). 
Via InvestorPlace
News headline image
Nasdaq Down Over 3%; IsoPlexis Shares Spike Higher ↗
U.S. stocks traded lower midway through trading, with the Dow Jones dropping around 600 points on Thursday. 
Via Benzinga
News headline image
Dow Tumbles 300 Points; US Economy Expands 3.2% In Q3 ↗
U.S. stocks traded lower this morning, with the Dow Jones dropping over 300 points on Thursday. 
Via Benzinga
News headline image
ProQR Therapeutics Shares Soar As Eli Lilly Expands RNA Collaboration ↗
 
Via Benzinga
News headline image
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday ↗
We're starting off the day with a breakdown of the biggest pre-market stock movers traders need to keep an eye on for Thursday! 
Via InvestorPlace
News headline image
ProQR Announces Conference Call to Discuss Axiomer® RNA Editing Platform
From ProQR Therapeutics N.V.
Via GlobeNewswire
News headline image
Lilly and ProQR to Expand RNA Editing Collaboration
New agreement supports the discovery and development of additional assets directed toward high conviction targets utilizing ProQR’s Axiomer technology 
From ProQR Therapeutics N.V.
Via GlobeNewswire
News headline image
ProQR to Present its Axiomer® RNA Editing Technology at the Oligonucleotide and Peptide Therapeutics Conference (TIDES Europe) 2022
From ProQR Therapeutics N.V.
Via GlobeNewswire
News headline image
ProQR Announces Third Quarter 2022 Operating and Financial Results
From ProQR Therapeutics N.V.
Via GlobeNewswire
News headline image
ProQR Announces Webcast of Presentation at the Upcoming Stifel 2022 Healthcare Conference
From ProQR Therapeutics N.V.
Via GlobeNewswire
< Previous 1 2 3 4 5 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.